News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Florian Lordick: Novel Data and Future Challenges of Upper GI Cancers at ESMO GI 2025
Florian Lordick/LinkedIn
Jul 6, 2025, 17:27

Florian Lordick: Novel Data and Future Challenges of Upper GI Cancers at ESMO GI 2025

Florian Lordick, Professor of Medicine at the University of Leipzig, shared a post on LinkedIn:

“ESMO – European Society for Medical Oncology Comprehensive discussion of current management, novel data and future challenges of Upper GI Cancers at ESMO GI 2025.

Proud to be involved as a speaker on the topic of management of resectable adenocarcinoma together with Guillaume Piessen (ESCC), Yelena Janjigian (immunotherapy) and Elizabeth Smyth (novel targets).”

Upper GI Cancers at ESMO GI 2025

More posts featuring ESMO GI 2025 on OncoDaily.

cancer Elizabeth Smyth ESMO ESMO - European Society for Medical Oncology ESMO GI 2025 European Society for Medical Oncology Guillaume Piessen OncoDaily Oncology Upper GI Cancers Yelena Janjigian
Special Coverage
Voices
Aug 18, 2025, 17:43
Building a Healthier Future for Women Also Means Building a Healthier Future for the Next Generation - Elekta Foundation
Voices
Aug 18, 2025, 17:35
Mandar Muzumdar: The Evolution of Single-Cell 3D Genomes in KRAS-Driven Cancers
Blog Posts
Aug 18, 2025, 17:21
Douglas Flora: Create the Things You Wish Existed
Blog Posts
Aug 18, 2025, 17:13
Matt Yurgelun: Thrilled to Be Joining The Jimmy Fund Radio-Telethon
Voices
Aug 18, 2025, 17:04
Striking out Cancer for Patients Like Charlie - The Jimmy Fund
Insight
Aug 18, 2025, 16:52
Darren Haywood: Pleased to Receive COSA Endorsement of the MASCC COG-IMPACT Tool
Science
Aug 18, 2025, 16:48
Petros Grivas: Highlighting Intra-Patient Tumor Heterogeneity in Prostate Cancer Research
Science
Aug 18, 2025, 16:46
How Do We Select the Best 2L Therapy for Advanced EGFR‑Mutant NSCLC After Osimertinib? - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 16:37
Amanda Impellizzeri: What a Weekend at the Carolina Cancer Conference
Science
Aug 18, 2025, 16:33
Maria Tolia: New Study on Cardio-Oncology Considerations for Breast Cancer
Science
Aug 18, 2025, 16:25
The Findings from AICR and WCRF Research on World Breast Cancer Research Day
Voices
Aug 18, 2025, 16:10
Hung Trinh: Pfizer Completes Licensing Agreement with 3SBio